Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens JM DiNapoli, A Kotelkin, L Yang, S Elankumaran, BR Murphy, SK Samal, ... Proceedings of the National Academy of Sciences 104 (23), 9788-9793, 2007 | 168 | 2007 |
Attenuation of human respiratory syncytial virus by genome-scale codon-pair deoptimization C Le Nouën, LG Brock, C Luongo, T McCarty, L Yang, M Mehedi, ... Proceedings of the National Academy of Sciences 111 (36), 13169-13174, 2014 | 128 | 2014 |
Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly … JM DiNapoli, L Yang, A Suguitan Jr, S Elankumaran, DW Dorward, ... Journal of Virology 81 (21), 11560-11568, 2007 | 122 | 2007 |
CX3CR1 is expressed in differentiated human ciliated airway cells and co-localizes with respiratory syncytial virus on cilia in a G protein-dependent manner KI Jeong, PA Piepenhagen, M Kishko, JM DiNapoli, RP Groppo, L Zhang, ... PloS one 10 (6), e0130517, 2015 | 115 | 2015 |
Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge … JM DiNapoli, B Nayak, L Yang, BW Finneyfrock, A Cook, H Andersen, ... Journal of virology 84 (3), 1489-1503, 2010 | 108 | 2010 |
Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response JM DiNapoli, L Yang, SK Samal, BR Murphy, PL Collins, A Bukreyev Vaccine 29 (1), 17-25, 2010 | 93 | 2010 |
Computationally optimized broadly reactive hemagglutinin elicits hemagglutination inhibition antibodies against a panel of H3N2 influenza virus cocirculating variants TM Wong, JD Allen, AG Bebin-Blackwell, DM Carter, T Alefantis, ... Journal of virology 91 (24), 10.1128/jvi. 01581-17, 2017 | 88 | 2017 |
Elicitation of protective antibodies against a broad panel of H1N1 viruses in ferrets preimmune to historical H1N1 influenza viruses DM Carter, CA Darby, SK Johnson, MA Carlock, GA Kirchenbaum, ... Journal of virology 91 (24), 10.1128/jvi. 01283-17, 2017 | 64 | 2017 |
Mucosal parainfluenza virus-vectored vaccine against Ebola virus replicates in the respiratory tract of vector-immune monkeys and is immunogenic AA Bukreyev, JM DiNapoli, L Yang, BR Murphy, PL Collins Virology 399 (2), 290-298, 2010 | 63 | 2010 |
Contributions of the avian influenza virus HA, NA, and M2 surface proteins to the induction of neutralizing antibodies and protective immunity B Nayak, S Kumar, JM DiNapoli, A Paldurai, DR Perez, PL Collins, ... Journal of virology 84 (5), 2408-2420, 2010 | 57 | 2010 |
Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza S Chivukula, T Plitnik, T Tibbitts, S Karve, A Dias, D Zhang, R Goldman, ... npj Vaccines 6 (1), 153, 2021 | 52 | 2021 |
Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans JM DiNapoli, JM Ward, L Cheng, L Yang, S Elankumaran, BR Murphy, ... Vaccine 27 (10), 1530-1539, 2009 | 48 | 2009 |
Development of a Pan-H1 influenza vaccine N Darricarrère, S Pougatcheva, X Duan, RS Rudicell, TH Chou, ... Journal of virology 92 (22), 10.1128/jvi. 01349-18, 2018 | 45 | 2018 |
Genetic stability of genome-scale deoptimized RNA virus vaccine candidates under selective pressure C Le Nouën, T McCarty, M Brown, ML Smith, R Lleras, MA Dolan, ... Proceedings of the National Academy of Sciences 114 (3), E386-E395, 2017 | 44 | 2017 |
Immunogenicity and efficacy of intramuscular replication-defective and subunit vaccines against herpes simplex virus type 2 in the mouse genital model S Delagrave, H Hernandez, C Zhou, JF Hamberger, ST Mundle, J Catalan, ... Public Library of Science 7 (10), e46714, 2012 | 44 | 2012 |
Elicitation of protective antibodies against 20 years of future H3N2 cocirculating influenza virus variants in ferrets preimmune to historical H3N2 influenza viruses JD Allen, H Jang, J DiNapoli, H Kleanthous, TM Ross Journal of virology 93 (3), 10.1128/jvi. 00946-18, 2019 | 41 | 2019 |
Impairment of the CD8+ T cell response in lungs following infection with human respiratory syncytial virus is specific to the anatomical site rather than the virus, antigen, or … JM DiNapoli, BR Murphy, PL Collins, A Bukreyev Virology journal 5, 1-8, 2008 | 41 | 2008 |
Comparison of adjuvants to optimize influenza neutralizing antibody responses RS Rudicell, M Garinot, M Kanekiyo, HD Kamp, K Swanson, T Chou, ... Vaccine 37 (42), 6208-6220, 2019 | 24 | 2019 |
A computationally designed H5 antigen shows immunological breadth of coverage and protects against drifting avian strains TM Ross, J DiNapoli, M Giel-Moloney, CE Bloom, K Bertran, C Balzli, ... Vaccine 37 (17), 2369-2376, 2019 | 24 | 2019 |
Immunogenicity of novel mRNA COVID-19 vaccine MRT5500 in mice and non-human primates KV Kalnin, T Plitnik, M Kishko, J Zhang, D Zhang, A Beauvais, ... BioRxiv, 2020.10. 14.337535, 2020 | 20 | 2020 |